CN107913279A - 一种治疗多种皮肤病的药膏 - Google Patents

一种治疗多种皮肤病的药膏 Download PDF

Info

Publication number
CN107913279A
CN107913279A CN201711133706.5A CN201711133706A CN107913279A CN 107913279 A CN107913279 A CN 107913279A CN 201711133706 A CN201711133706 A CN 201711133706A CN 107913279 A CN107913279 A CN 107913279A
Authority
CN
China
Prior art keywords
ointment
treating multiple
camphors
albolene
mountain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711133706.5A
Other languages
English (en)
Inventor
钟汝华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201711133706.5A priority Critical patent/CN107913279A/zh
Publication of CN107913279A publication Critical patent/CN107913279A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A61K31/125—Camphor; Nuclear substituted derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明公开了一种治疗多种皮肤病的药膏，包括以下重量配比组分：2.5‑4mg地塞米松、2.5‑3g水杨酸、10mg樟脑、10mg薄荷脑、1‑2mg丙二醇、1‑2mg十八醇、2‑3mg3480香精、3‑5g纯化水、0.5‑1g甘油、3‑5g无水亚硫酸钠、0.5‑1g白凡士林、5‑8mg聚山利脂60、1‑2mg单双硬脂酸甘油脂、0.5‑1g轻质液状石蜡，本发明以杀灭各种细菌为主，对对肥厚型神经性皮炎、手癣、足癣、体癣、股癣、甲癣、顽癣、汗斑、甲沟炎、疮节、脆甲、肛周痒等有显著疗效，成本低，可以减少患者的经济负担。

Description

一种治疗多种皮肤病的药膏
技术领域
本发明涉及一种药膏，特别涉及一种治疗多种皮肤病的药膏。
背景技术
皮肤病多种原因引起，有真菌，球菌，杆菌或自身免疫性疾病等。症状有痒有痛有碍雅观。目前常用水剂，乳膏，口服药疗效局限不理想，增加患者经济负担，尤其对肥厚型神经性皮炎、手癣、足癣、体癣、股癣、甲癣、顽癣、汗斑、甲沟炎、疮疖、脆甲、肛周痒等药效不明显。
发明内容
为解决上述问题，本发明提供一种治疗多种皮肤病的药膏，本发明以杀灭各种细菌为主，对对肥厚型神经性皮炎、手癣、足癣、体癣、股癣、甲癣、顽癣、汗斑、甲沟炎、疮疖、脆甲、肛周痒等有显著疗效，成本低，可以减少患者的经济负担。
为实现上述目的，本发明采用以下技术手段：
本发明提供一种治疗多种皮肤病的药膏，包括以下重量配比组分：2.5-4mg地塞米松、2.5-3g水杨酸、
10mg樟脑、10mg薄荷脑、1-2mg丙二醇、1-2mg十八醇、2-3mg3480香精、3-5g纯化水、0.5-1g甘
油、3-5g无水亚硫酸钠、0.5-1g白凡士林、5-8mg聚山利脂60、1-2mg单双硬脂酸甘油脂、0.5-1g
轻质液状石蜡。
进一步的，包括以下重量配比组分：2.5mg地塞米松、2.5g水杨酸、10mg樟脑、10mg薄荷脑、1mg丙二醇、1mg十八醇、2mg3480香精、3g纯化水、0.5g甘油、3g无水亚硫酸钠、0.5-1g白凡士林、5-8mg聚山利脂60、1-2mg单双硬脂酸甘油脂、0.5-1g轻质液状石蜡。
进一步的，包括以下重量配比组分：4mg地塞米松、3g水杨酸、10mg樟脑、10mg薄荷脑、2mg丙二醇、2mg十八醇、3mg3480香精、5g纯化水、1g甘油、5g无水亚硫酸钠、1g白凡士林、8mg聚山利脂60、2mg单双硬脂酸甘油脂、1g轻质液状石蜡。
进一步的，包括以下重量配比组分：3mg地塞米松、2.8g水杨酸、10mg樟脑、10mg薄荷脑、1.5mg丙二醇、1.5mg十八醇、2.5mg3480香精、4g纯化水、0.8g甘油、4g无水亚硫酸钠、0.7g白凡士林、6mg聚山利脂60、1.5mg单双硬脂酸甘油脂、0.6g轻质液状石蜡。
本发明还提供一种制作上述药膏的方法，包括将各组分原料用搅拌机进行充分搅拌后得到药膏。
本发明的有益效果：
本发明以杀灭各种细菌为主，对对肥厚型神经性皮炎、手癣、足癣、体癣、股癣、甲癣、顽癣、汗斑、甲沟炎、疮疖、脆甲、肛周痒等有显著疗效，成本低，可以减少患者的经济负担。
具体实施方式
下面结合具体实施例对本发明做进一步说明。
实施例1：本实施例提供一种治疗多种皮肤病的药膏，包括以下重量配比组分：2.5mg地塞米松、2.5g水杨酸、10mg樟脑、10mg薄荷脑、1mg丙二醇、1mg十八醇、2mg3480香精、3g纯化水、0.5g甘油、3g无水亚硫酸钠、0.5-1g白凡士林、5-8mg聚山利脂60、1-2mg单双硬脂酸甘油脂、0.5-1g轻质液状石蜡。
将上述各组分原料用搅拌机进行充分搅拌后得到药膏，患者甲常年患有肥厚型神经性皮炎，开始使用此药膏，将药膏涂抹在患处，出现灼痛停药即可，患者使用一周后，瘙痒症状明显减缓，皮疹面积明显减少，使用一个月后瘙痒症状消失，皮疹消失，重新生出新嫩肌肤。
实施例2：本实施例提供一种治疗多种皮肤病的药膏，包括以下重量配比组分：4mg地塞米松、3g水杨酸、10mg樟脑、10mg薄荷脑、2mg丙二醇、2mg十八醇、3mg3480香精、5g纯化水、1g甘油、5g无水亚硫酸钠、1g白凡士林、8mg聚山利脂60、2mg单双硬脂酸甘油脂、1g轻质液状石蜡。
将上述各组分原料用搅拌机进行充分搅拌后得到药膏，患者乙常年患有足癣，开始使用此药膏，将药膏涂抹在患处，出现灼痛停药即可，患者使用一周后，瘙痒症状明显减缓，皮疹面积明显减少，使用三周后瘙痒症状消失，皮疹消失，重新生出新嫩肌肤。
实施例3：本实施例提供一种治疗多种皮肤病的药膏，包括以下重量配比组分：3mg地塞米松、2.8g水杨酸、10mg樟脑、10mg薄荷脑、1.5mg丙二醇、1.5mg十八醇、2.5mg3480香精、4g纯化水、0.8g甘油、4g无水亚硫酸钠、0.7g白凡士林、6mg聚山利脂60、1.5mg单双硬脂酸甘油脂、0.6g轻质液状石蜡。
将上述各组分原料用搅拌机进行充分搅拌后得到药膏，患者丙常年患有甲沟炎，开始使用此药膏，将药膏涂抹在患处，出现灼痛停药即可，患者使用一周后，疼痛症状明显减缓，红肿面积明显减少，使用一个月后疼痛症状消失，红肿消失，重新生出新嫩肌肤。
实施例4：本实施例提供一种治疗多种皮肤病的药膏，包括以下重量配比组分：3.2mg地塞米松、2.6g水杨酸、10mg樟脑、10mg薄荷脑、1.5mg丙二醇、1.5mg十八醇、2.5mg3480香精、4g纯化水、0.8g甘油、4g无水亚硫酸钠、0.7g白凡士林、6mg聚山利脂60、1.5mg单双硬脂酸甘油脂、0.6g轻质液状石蜡。
将上述各组分原料用搅拌机进行充分搅拌后得到药膏，患者丁常年患有痔疮，开始使用此药膏，将药膏涂抹在患处，出现灼痛停药即可，患者使用一周后，痛痒症状明显减缓，使用一个月后痛痒症状消失。
最后所应当说明的是，以上实施例仅用以说明本发明的技术方案而非对本发明保护范围的限制，尽管参照较佳实施例对本发明作了详细说明，本领域的普通技术人员应当理解，可以对本发明的技术方案进行修改或者等同替换，而不脱离本发明技术方案的实质和范围。

Claims (5)

1.一种治疗多种皮肤病的药膏，其特征在于，包括以下重量配比组分：2.5-4mg地塞米松、2.5-3g水杨酸、10mg樟脑、10mg薄荷脑、1-2mg丙二醇、1-2mg十八醇、2-3mg3480香精、3-5g纯化水、0.5-1g甘油、3-5g无水亚硫酸钠、0.5-1g白凡士林、5-8mg聚山利脂60、1-2mg单双硬脂酸甘油脂、0.5-1g轻质液状石蜡。
2.根据权利要1所述的一种治疗多种皮肤病的药膏，其特征在于，包括以下重量配比组分：2.5mg地塞米松、2.5g水杨酸、10mg樟脑、10mg薄荷脑、1mg丙二醇、1mg十八醇、2mg3480香精、3g纯化水、0.5g甘油、3g无水亚硫酸钠、0.5-1g白凡士林、5-8mg聚山利脂60、1-2mg单双硬脂酸甘油脂、0.5-1g轻质液状石蜡。
3.根据权利要1所述的一种治疗多种皮肤病的药膏，其特征在于，包括以下重量配比组分：4mg地塞米松、3g水杨酸、10mg樟脑、10mg薄荷脑、2mg丙二醇、2mg十八醇、3mg3480香精、5g纯化水、1g甘油、5g无水亚硫酸钠、1g白凡士林、8mg聚山利脂60、2mg单双硬脂酸甘油脂、1g轻质液状石蜡。
4.根据权利要1所述的一种治疗多种皮肤病的药膏，其特征在于，包括以下重量配比组分：3mg地塞米松、2.8g水杨酸、10mg樟脑、10mg薄荷脑、1.5mg丙二醇、1.5mg十八醇、2.5mg3480香精、4g纯化水、0.8g甘油、4g无水亚硫酸钠、0.7g白凡士林、6mg聚山利脂60、1.5mg单双硬脂酸甘油脂、0.6g轻质液状石蜡。
5.制作如权利要1-4任一项所述的一种治疗多种皮肤病的药膏的方法，其特征在于,包括将各组分原料用搅拌机进行充分搅拌后得到药膏。
CN201711133706.5A 2017-11-16 2017-11-16 一种治疗多种皮肤病的药膏 Pending CN107913279A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711133706.5A CN107913279A (zh) 2017-11-16 2017-11-16 一种治疗多种皮肤病的药膏

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711133706.5A CN107913279A (zh) 2017-11-16 2017-11-16 一种治疗多种皮肤病的药膏

Publications (1)

Publication Number Publication Date
CN107913279A true CN107913279A (zh) 2018-04-17

Family

ID=61896541

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711133706.5A Pending CN107913279A (zh) 2017-11-16 2017-11-16 一种治疗多种皮肤病的药膏

Country Status (1)

Country Link
CN (1) CN107913279A (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110559259A (zh) * 2019-09-23 2019-12-13 郭小兵 一种治疗皮肤顽癣疾病的膏药

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1092651A (zh) * 1993-12-06 1994-09-28 广东医学院 外用皮质激素复方制剂
WO2005048927A2 (en) * 2003-11-13 2005-06-02 Combinatorx, Incorporated Methods and reagents for the treatment of inflammatory disorders
CN102366437A (zh) * 2011-07-15 2012-03-07 吉林敖东集团大连药业股份有限公司 一种复方地塞米松软膏及其制备方法
CN105616426A (zh) * 2015-07-09 2016-06-01 广州白云山医药集团股份有限公司白云山何济公制药厂 一种复方醋酸地塞米松纳米乳膏及其制备方法
CN105687207A (zh) * 2016-02-26 2016-06-22 江西省皮肤病专科医院 一种用于皮炎、湿疹的膏剂及其制备方法

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1092651A (zh) * 1993-12-06 1994-09-28 广东医学院 外用皮质激素复方制剂
WO2005048927A2 (en) * 2003-11-13 2005-06-02 Combinatorx, Incorporated Methods and reagents for the treatment of inflammatory disorders
CN102366437A (zh) * 2011-07-15 2012-03-07 吉林敖东集团大连药业股份有限公司 一种复方地塞米松软膏及其制备方法
CN105616426A (zh) * 2015-07-09 2016-06-01 广州白云山医药集团股份有限公司白云山何济公制药厂 一种复方醋酸地塞米松纳米乳膏及其制备方法
CN105687207A (zh) * 2016-02-26 2016-06-22 江西省皮肤病专科医院 一种用于皮炎、湿疹的膏剂及其制备方法

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110559259A (zh) * 2019-09-23 2019-12-13 郭小兵 一种治疗皮肤顽癣疾病的膏药

Similar Documents

Publication Publication Date Title
Al‐Waili Clinical and mycological benefits of topical application of honey, olive oil and beeswax in diaper dermatitis
EP1776128B1 (en) Compositions for topical treatment
DE69724450T2 (de) Verwendung von metallkomplexe zur behandlung von magen/darm-infektionen
Camarasa et al. Calcitriol shows greater persistence of treatment effect than betamethasone dipropionate in topical psoriasis therapy
US20120022019A1 (en) Medicinal Steroids Cream And A Process To Make It
Bakker et al. Dermatological preparations for the tropics. A formulary of dermatological preparations and background information on choices, production and dispensing.
EP1867322B1 (en) Topical composition for the treatment of psoriasis
Areses Trapote et al. Hereditary hypophosphatemic rickets with hypercalciuria: case report
AU2005293830A1 (en) Acidic and buffered skin-care compositions comprising nicotinamid and an absorbing agent
CN107913279A (zh) 一种治疗多种皮肤病的药膏
Goodfield et al. Double‐blind, randomised, multicentre, parallel group study comparing a 1% coal tar preparation (Exorex) with a 5% coal tar preparation (Alphosyl) in chronic plaque psoriasis
Lopez de Romaña et al. Review of intervention products for use in the prevention and control of anemia
Kazemi et al. Effect of green tea ointment on perineal pain and wound healing after episiotomy: A randomized double-blind clinical trial
CA2179628C (en) Psoriasis treatment
Tamayo et al. Botanical regulation: comparison of the United States and Canada
US20120108539A1 (en) Medicinal Anti Acne Cream And A Process To Make It
WO2022254446A1 (en) Method for the treatment of microbial overgrowth, imbalance and infections
JP2010018550A (ja) 皮膚用塗布剤
WO2021180896A1 (en) Topical preparations
WO2010109433A1 (en) An antiviral medicinal cream and a process to make it
US20060165610A1 (en) Composition for Treating and Preventing Periodontal Disease and Method of Use
CN104623062A (zh) 治疗痘痘的药物组合物
WO2010109421A1 (en) A medicinal antifungal and steroids cream comprising chitosan and a process to make it
WO2015153863A1 (en) Copper/zinc superoxide dismutase (sod) formulation for the treatment of traumas including amyotropic lateral sclerosis
CN107811908A (zh) 一种含有灵芝孢子提取物的抑菌消炎、净白组合物及其制备方法

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20180417

RJ01 Rejection of invention patent application after publication